Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Prediction of intraoperative hypothermia risk
The First People's Hospital of Lianyungang
Intraoperative Hypothermia
1 trial -
Prednisolone
The First People's Hospital of Lianyungang
HIV (Human Immunodeficiency Virus)
1 trial -
Prednisolone and/or AZA/MMF
United Therapeutics Europe Ltd
Lupus Nephritis
1 trial -
Probiotic
United Therapeutics Europe Ltd
Stress Physiology
1 trial -
Propofol
The University of Hong Kong
Anesthesia
1 trial -
Propranolol
Eli Lilly and Company
Healthy
1 trial -
Propranolol + Bleomycin
Universal Integrated
Infantile Hemangioma (IH)
1 trial -
Propranolol Hydrochloride
United Therapeutics Europe Ltd
Post-traumatic Stress Disorder
1 trial -
Prostate biopsy
United Therapeutics Europe Ltd
Prostate Cancer
1 trial -
Prostate biopsy guided by PSMA PET/CT
The First People's Hospital of Lianyungang
PSMA PET/CT
1 trial -
Protein intake
Ultragenyx UK Limited
Phenylketonuria
1 trial -
Protocol-based management of perioperative antithrombotic therapy
Peking University Third Hospital
Antithrombotic Therapy
1 trial -
Protocol-based management of perioperative antithrombotic therapy
The First People's Hospital of Lianyungang
Antithrombotic Therapy
1 trial -
Prunes
United Therapeutics Europe Ltd
Perimenopausal Bone Loss
1 trial -
Pueraria lobata radix
The First People's Hospital of Lianyungang
Type 2 Diabetes Mellitus
1 trial -
Pyridoxal-5'-Phosphate supplement
AVENUE THERAPEUTICS, INC.
Neural Inhibition
1 trial -
Qingre Huashi Granules combined the modified dual therapy
The First People's Hospital of Lianyungang
Helicobacter Pylori Infection
1 trial -
R-CDOP
The First People's Hospital of Lianyungang
Diffuse Large B Cell Lymphoma
1 trial -
RB001
The First People's Hospital of Lianyungang
Phelan-McDermid Syndrome
1 trial -
REMIMAZOLAM BESYLATE 2.5 Mg in 1 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, for SOLUTION [BYFAVO]
Hospital Authority, Hong Kong
Hemodynamic Instability
1 trial -
RSV A Memphis 37
United Therapeutics Europe Ltd
Respiratory Syncytial Virus Infections
1 trial -
Rabeprazole 20mg twice daily
Hospital Authority, Hong Kong
Chest Pain
1 trial -
Radiation therapy
United Therapeutics Europe Ltd
Breast Cancer
1 trial -
Radiotherapy combined with TKI and Anti-PD-1 Antibody
Jian Li
Stage IIIA Hepatocellular Carcinoma
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources